TANG Qing-Qiu, JIANG Jing-Yan, YANG Chu-Fen, JU Xiao-Ting, DONG Xiao-Yang . Research and development of Lipin family[J]. Hereditas(Beijing), 2010 , 32(10) : 981 -993 . DOI: 10.3724/SP.J.1005.2010.00981

[1] Garg A. Acquired and inherited lipodystrophies. N Engl J Med, 2004, 350(1): 1220–1234. [2] Hegele RA, Joy TR, Al-Attar S, Rutt BK. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res, 2007, 48(7): 1433–1444. [3] Reue K, Phan J. Metabolic consequences of lipodystrophy in mouse models. Curr Opin Clin Nutr Metab Care, 2006, 9(4): 436–441. [4] Ahima RS. Adipose tissue as an endocrine organ. Obesity, 2006, 14(Suppl. 5): 242S–249S. [5] Unger RH. Lipotoxic diseases. Annu Rev Med, 2002, 53(1): 319–336. [6] Farmer SR. Transcriptional control of adipocyte formation. Cell Metab, 2006, 4(4): 263–273. [7] Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Na Rev Mol Cell Biol, 2006, 7(12): 885–896. [8] Phan J, Péterfy M, Reue K. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J Biol Chem, 2004, 279(28): 29558–29564. [9] van Harmelen V, Ryden M, Sjolin E, Hoffstedt J. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J Lipid Res, 2007, 48(1): 201–206. [10] Langner CA, Birkenmeier EH, Ben-Zeev O, Schotz MC, Sweet HO, Davisson MT, Gordon JI. The fatty liver dys-trophy (fld) mutation. A new mutant mouse with a devel-opmental abnormality in triglyceride metabolism and as-sociated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J Biol Chem, 1989, 264(14): 7994–8003. [11] Langner CA, Birkenmeier EH, Roth KA, Bronson RT, Gordon JI. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J Biol Chem, 1991, 266(18): 11955–11964. [12] Reue K, Xu P, Wang XP, Slavin BG. Adipose tissue defi-ciency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J Lipid Res, 2000, 41(7): 1067–1076. [13] Péterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet, 2001, 27(1): 121–124. [14] Huffman TA, Mothe-Satney I, Lawrence JC Jr. Insu-lin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc Natl Acad Sci USA, 2002, 99(2): 1047–1052. [15] Péterfy M, Phan J, Reue K. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J Biol Chem, 2005, 280(38): 32883–32889. [16] Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr, Kelly DP. Lipin 1 is an induc-ible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab, 2006, 4(3): 199–210. [17] Han GS, Wu WI, Carman GM. The Saccharomyces cere-visiae lipin homolog is an Mg²⁺-dependent phosphatidate phosphatase enzyme. J Biol Chem, 2006, 281(14): 9210–9218. [18] Han GS, Siniossoglou S, Carman GM. The cellular func-tions of the yeast lipin homolog PAH1p are dependent on its phosphatidate phosphatase activity. J Biol Chem, 2007, 282(51): 37026–37035. [19] O'Hara L, Han GS, Peak-Chew S, Grimsey N, Carman GM, Siniossoglou S. Control of phospholipid synthesis by phosphorylation of the yeast lipin Pah1p/Smp2p Mg²⁺-dependent phosphatidate phosphatase. J Biol Chem, 2006, 281(45): 34537–34548. [20] He XP, Xu XW, Zhao SH, Fan B, Yu M, Zhu MJ, Li CC, Peng ZZ, Liu B. Investigation of Lpin1 as a candidate gene for fat deposition in pigs. Mol Biol Rep, 2009, 36(5): 1175–1180. [21] He XP, Xu XW, Liu B. Molecular characterization, chro-mosomal locali